Conditions: Diabetes Diabetes Mellitus, Type 2
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 244
Healthy volunteers: no

Brief summary:
This trial is conducted in the United States of America. The aim of this trial is to explore how different fasting blood glucose targets affect glucose control in patients with type 2 diabetes, when patients are empowered to do dose adjustments themselves.

Detailed description:

Arms:
arm 1: Aggressive FPG (fasting plasma glucose) titration target range group arm 2: Conventional FPG (fasting plasma glucose) titration target range group

Interventions: intervention 1: insulin detemir intervention 2: insulin detemir
Intervention descriptions: intervention 1: Treat-to-target dose titration scheme, s.c. injection, once daily. Fasting plasma glucose (FPG) titration target range of 70-90 mg/dL intervention 2: Treat-to-target dose titration scheme, s.c. injection, once daily. Fasting plasma glucose (FPG) titration target range of 80-110 mg/dL

Protocol document: